Be the first to like this
Presentation given at the 11th Annual Biotech in Europe Investor Forum 13-14 September 2011 in Zurich by Thomas Christély. Chief Operating Officer of Silence Therapeutics. Silence Therapeutics is involved in the development and delivery of RNAi therapeutics for the treatment of serious diseases, such as lung cancer.
Clipping is a handy way to collect important slides you want to go back to later.